Тиреоидный статус у лиц с ожирением
https://doi.org/10.14341/ket20117257-62
Аннотация
Об авторах
S V Mustafinaканд. мед. наук, старший научный сотрудник лаборатории клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний НИИ терапии СО РАМН
O D Rymar
доктор мед. наук, ведущий научный сотрудник лаборатории клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний НИИ терапии СО РАМН
G I Simonova
профессор, доктор мед. наук, заместитель директора НИИ терапии СО РАМН, заведующая кафедрой эпидемиологии и профилактики ХНИЗ НГМУ
L V Scherbakova
старший научный сотрудник лаборатории клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний НИИ терапии СО РАМН
Список литературы
1. Гилман А.Г., Хардман Дж., Лимберд Л. Клиническая фармакология по Гудману и Гилману / Пер. с англ. М., Практика, 2006.
2. Bastemir M., Akin F., Alkis E. et al. Obesity is associated with increased serum TSH level, independent of thyroid function // Swiss. Med. Wkly. 2007. V. 137. Р. 29–30.
3. Canani L.H., Capp C., Dora J.M. et al. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus // J. Clin. Endocrinol. Metab. 2005. V. 90. P. 3472–823.
4. de Pergola G., Ciampolillo A., Paolotti S. et al. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women // Clin. Endocr. 2007. V. 67. P. 9–265.
5. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults // JAMA. 2001. V. 285. P. 2486–2497.
6. Galofé J., Frühbeck G., Salvador J. Obesity and thyroid function: pathorhysiological and therapeutic implications // Hot Thyroidol. 2010. V. 6. P. 2075–2202.
7. Knudsen N., Laurberg P., Rasmussen L.B. et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population // J. Clin. Endocr. Met. 2005. V. 90. P. 4019–4024.
8. Lewandowski K., Randeva H.S., O`Callagham C.J. et al. Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin // Clin. Endocrin. 2001. V. 54. P. 533–539.
9. Manji N., Boelaert K., Sheppard M.C. et al. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects// Clin. Endocrinol. 2006. V. 64. P. 125–128.
10. Mantzoros C.S., Moschol S.J. Leptin: in search of role(s) in human physiology // Clinical Endocrinology. 1998. V.49. P.551–567.
11. Menendez C., Baldelli R., Camina J.P. et al. TSH stimulates leptin secretion by a direct effect on adipocytes // J. Endocrinol. 2003. V. 176. P. 7–12.
12. Mentucca D., Proietti Pannunzi L. Tanner K. et al. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance // Diabetes. 2002. V. 51. P. 880–883.
13. Michalaki M.A., Vagenakis A.G., Leonardou A.S. et al. Thyroid function in humans with morbid obesity // Thyroid. 2006. V. 16. P. 73–78.
14. Pontikides N., Krassas G.E. Basic endocrine products of adipose tissue in states of thyroid dysfunction// Thyroid. 2007. V. 17. P. 421–431.
15. Reinehr T. Obesity and thyroid function // Mol. Cell. Endocr. 2010. V. 316. P. 165–171.
16. Rosenbaun M., Hirsch J., Murphy E. et al. Effects of changes in body weight on carbohadrate metabolism, catecholamine excretion, and thyroid function // Am. J. Clin. Nutrit. 2000. V. 71. P. 1421–1432.
17. Sari R., Kemal Balci M., Altunbas H. et al. The effect of body weight and weight loss on thyroid volume and function in obese women // Clin. Endocrinol. 2003. V. 59. P. 258–262.
18. Chaffler A., Binart N., Scholmerich J. et al. Hypothesis paper brain talks with fat – evidence for a hypothalamic–pituitary–adipose axis? // Neuropeptid. 2005. V. 39. P. 363–367.
19. Sorisky A., Bell A. Gagnon A. TSH receptor in adipose cells // Hormon. Met. Res. 2000. V. 32. P. 468–474.
20. Valyasevi R.W., Harteneck D.A., Dutton C.M. et al. Stimulation (PPAR gamma), and thyrotropin receptor by PPAR gamma agonist in human orbital preadipocyte fibroblasts // J. Clin. Endocrinol. Met. 2002. V. 87. P. 2352–2358.
21. Weiss R.E., Brown R.L. Doctor… cold it be my thyroid? // Arch. Intern. Med. 2008. V. 168. P. 568–569.
22. Yen P.M. Physiological and molecular basis of thyroid hormone action // Physiol. Rev. 2001. V. 81. P. 1097–1142.
23. Zimmermann Belsing T., Brabant G., Holst J.J. et al. Circulating leptin and thyroid dysfunction // Eur. J. Endocrinol. 2003. V. 149. P. 257–271.
Рецензия
Для цитирования:
Mustafina S.V., Rymar O.D., Simonova G.I., Scherbakova L.V. Тиреоидный статус у лиц с ожирением. Клиническая и экспериментальная тиреоидология. 2011;7(2):57-62. https://doi.org/10.14341/ket20117257-62
For citation:
, , , Thyroid function in the people with obesity. Clinical and experimental thyroidology. 2011;7(2):57-62. (In Russ.) https://doi.org/10.14341/ket20117257-62

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).